Inify Laboratories is to move to Milton Park’s new Nebula building.
The Swedish digital pathology and AI cancer diagnostics company is to set up its first UK laboratory in 11,620 sq ft of the new space at the building which was named Best Commercial Building at the OxProp Awards 2025.
The move will bring Inify’s clinical, laboratory and commercial functions together into a single building.
Kate Bucknall, managing director of Inify UK, said: “Our new base at Milton Park is a real milestone in our mission to improve cancer care and reduce delays in patient pathways. Our recent success shows that digitised, AI-supported workflows can halve the time from biopsy to diagnosis, which has been transformative for both patients and clinicians in Sweden.
“With around 120,000 prostate biopsy patients requiring support every year, the UK’s demand for diagnostics is around six times larger than in Sweden. In the UK, our ageing population, growing awareness and a national shortage of pathologists and biomedical scientists mean we have a significant bottleneck in prostate diagnosis.
“We want to tackle that challenge head-on in our new facility, by giving patients answers as soon as possible, while providing quality and efficiency gains across the pathway. The Inify lab will have capacity to handle a volume similar to the country’s total demand.
“After an extensive search, we chose Milton Park based on its vibrant community, strong transport links and access to exceptional talent near Oxford and London. Nebula was also ideal for us to build a state-of-the-art lab from scratch. The buildings’ eco-friendly credentials, timber frame and light-filled design aligns with our Scandinavian aesthetic and sustainability approach.
“The new space is welcoming, for both the Inify team and also for our clinicians and partners. From wellbeing events and sense of community to transport connections, the park is somewhere we feel people will want to come to work.”
Tom Booker, commercial manager for MEPC Milton Park, said: “We’re thrilled that Inify has chosen Milton Park as its UK home. The team’s decision to join the Milton Park community reinforces our position as a home for leading life science and med-tech organisations to collaborate, innovate and grow.
“Inify’s work in Sweden is a real example of how innovation can deliver meaningful impact in healthcare. We look forward to seeing the difference it can make on patient outcomes in its new UK base here at Milton Park.”
Image (l-r): Gareth Ralphs, Thames Valley Chamber of Commerce; Kate Bucknall, Inify UK; Fredrik Palm, Inify; Tom Booker, MEPC Milton Park.
© Thames Tap (powered by ukpropertyforums.com).
Sign up to receive our weekly free journal, The Forum here.
